FSRA issues notice of proposal against Nexus Seulal
TORONTO, Dec. 5, 2023 /CNW/ - The Financial Services Regulatory Authority of Ontario (FSRA) has initiated enforcement action against Nexus Seulal (Seulal).
FSRA alleges that Seulal's past conduct affords reasonable grounds for belief that he will not deal or trade in mortgages in accordance with the law and with integrity and honesty, and is therefore not suitable to be licenced as a mortgage agent.
FSRA is proposing to refuse to issue a mortgage agent licence to Seulal.
Seulal requested a hearing before the Financial Services Tribunal about this Proposal.
Learn more:
Access our enforcement database to see how FSRA is working to protect consumers through its monitoring and enforcement activities.
For media inquiries:
Russ Courtney Sr. Manager of Media Relations Financial Services Regulatory Authority C: 437-225-8551 Email: [email protected]
SOURCE Financial Services Regulatory Authority of Ontario
Montana Technologies Corporation ("Montana Technologies"), the developer of AirJoule®, a transformational atmospheric thermal energy and water harvesting technology, today announced its first quarter results....
Brown Gibbons Lang & Company (BGL) is pleased to announce the recapitalization of Musser Biomass and Wood Products ("Musser" or the "Company"), a leading producer of premium ESG-certified reclaimed biomass wood fiber, by the Watermill Group. BGL's...
Today Transamerica announced a new collaboration with FT Indexing Solutions LLC ("First Trust") that adds the First Trust Equity Edge Indextm to the popular and innovative Transamerica Structured Index Advantage® Annuity....
WildFire Energy I LLC ("WildFire"), today announced that it has entered into a definitive agreement for the acquisition of approximately 237,000 net acres and interests in 465 wells in the East Texas Eagle Ford from Apache Corporation and...
Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") today provided unaudited financial results for the quarter and year ended March 31, 2024.
Quarter ended March 31, 2024 Highlights ? compared to March 31, 2023
Net sales of $164.9...
Zepp Health Corporation ("Zepp" or the "Company") today reported revenues of US$39.8 million; a basic and diluted net loss per share of US$0.06; and a basic and diluted net loss per ADS of US$0.23 for the first quarter ended March 31, 2024;...
